Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Oligomenorrhea × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 916 Neoplasms 686 Carcinoma, Non-Small-Cell Lung 675 Prostatic Neoplasms 554 Colorectal Neoplasms 444 Lung Neoplasms 399 Neoplasm Metastasis 343 Multiple Myeloma 328 Leukemia, Myeloid, Acute 318 Ovarian Neoplasms 294 Melanoma 266 Squamous Cell Carcinoma of Head and Neck 244 Pancreatic Neoplasms 234 Recurrence 232 Brain Neoplasms 200 Glioblastoma 196 Carcinoma, Hepatocellular 189 Triple Negative Breast Neoplasms 187 Stomach Neoplasms 187 Uterine Cervical Neoplasms 181 Lymphoma 181 Endometrial Neoplasms 174 Head and Neck Neoplasms 169 Precursor Cell Lymphoblastic Leukemia-Lymphoma 164 Carcinoma, Renal Cell 160 Urinary Bladder Neoplasms 155 Leukemia, Lymphocytic, Chronic, B-Cell 149 Glioma 143 Sarcoma 142 Lymphoma, Non-Hodgkin 142

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06800170 2026-01-06

HP-phD_Adolesc

Lo.Li.Pharma s.r.l

Phase NA Recruiting

Amenorrhea, Oligomenorrhea, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡